Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy L Herrmann

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Shock (Augusta, Ga.)|May 12, 2010
Toll-like receptor signaling pathways and the evidence linking toll-like receptor signaling to cardiac ischemia/reperfusion injuryYue Wang, Aaron M Abarbanell, Jeremy L Herrmann, et al.
The Journal of Surgical Research|September 11, 2010
Optimizing stem cell function for the treatment of ischemic heart diseaseJeremy L Herrmann, Aaron M Abarbanell, Brent R Weil, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|April 1, 2011
Female stem cells are superior to males in preserving myocardial function following endotoxemiaMariuxi C Manukyan, Brent R Weil, Yue Wang, et al.
Surgery|August 2, 2011
Systemic pretreatment with dimethyloxalylglycine increases myocardial HIF-1α and VEGF production and improves functional recovery after acute ischemia/reperfusionJeffrey A Poynter, Mariuxi C Manukyan, Yue Wang, et al.
Journal of the American College of Surgeons|May 7, 2011
Intracoronary mesenchymal stem cells promote postischemic myocardial functional recovery, decrease inflammation, and reduce apoptosis via a signal transducer and activator of transcription 3 mechanismJeffrey A Poynter, Jeremy L Herrmann, Mariuxi C Manukyan, et al.
Surgery|August 21, 2010
Exogenous high-mobility group box 1 improves myocardial recovery after acute global ischemia/reperfusion injuryAaron M Abarbanell, Jacob A Hartley, Jeremy L Herrmann, et al.
The Journal of Clinical Investigation|July 30, 2024
Early ascertainment of genetic diagnoses clarifies impact on medium-term survival following neonatal congenital heart surgeryBenjamin J Landis, Benjamin M Helm, Matthew D Durbin, et al.
The Annals of Thoracic Surgery|February 24, 2009
Role of tumor necrosis factor receptor 1 in sex differences of stem cell mediated cardioprotectionCourtney N Zeller, Yue Wang, Troy A Markel, et al.
Journal of Cardiovascular Translational Research|April 9, 2010
Gender dimorphisms in progenitor and stem cell function in cardiovascular diseaseJeremy L Herrmann, Aaron M Abarbanell, Brent R Weil, et al.
The Annals of Thoracic Surgery|November 25, 2010
Surgical treatment of atrial fibrillation: the time is nowJeffrey A Poynter, Daniel J Beckman, Aaron M Abarbanell, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Shock (Augusta, Ga.)|May 12, 2010
Toll-like receptor signaling pathways and the evidence linking toll-like receptor signaling to cardiac ischemia/reperfusion injuryYue Wang, Aaron M Abarbanell, Jeremy L Herrmann, et al.
The Journal of Surgical Research|September 11, 2010
Optimizing stem cell function for the treatment of ischemic heart diseaseJeremy L Herrmann, Aaron M Abarbanell, Brent R Weil, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|April 1, 2011
Female stem cells are superior to males in preserving myocardial function following endotoxemiaMariuxi C Manukyan, Brent R Weil, Yue Wang, et al.
Surgery|August 2, 2011
Systemic pretreatment with dimethyloxalylglycine increases myocardial HIF-1α and VEGF production and improves functional recovery after acute ischemia/reperfusionJeffrey A Poynter, Mariuxi C Manukyan, Yue Wang, et al.
Journal of the American College of Surgeons|May 7, 2011
Intracoronary mesenchymal stem cells promote postischemic myocardial functional recovery, decrease inflammation, and reduce apoptosis via a signal transducer and activator of transcription 3 mechanismJeffrey A Poynter, Jeremy L Herrmann, Mariuxi C Manukyan, et al.
Surgery|August 21, 2010
Exogenous high-mobility group box 1 improves myocardial recovery after acute global ischemia/reperfusion injuryAaron M Abarbanell, Jacob A Hartley, Jeremy L Herrmann, et al.
The Journal of Clinical Investigation|July 30, 2024
Early ascertainment of genetic diagnoses clarifies impact on medium-term survival following neonatal congenital heart surgeryBenjamin J Landis, Benjamin M Helm, Matthew D Durbin, et al.
The Annals of Thoracic Surgery|February 24, 2009
Role of tumor necrosis factor receptor 1 in sex differences of stem cell mediated cardioprotectionCourtney N Zeller, Yue Wang, Troy A Markel, et al.
Journal of Cardiovascular Translational Research|April 9, 2010
Gender dimorphisms in progenitor and stem cell function in cardiovascular diseaseJeremy L Herrmann, Aaron M Abarbanell, Brent R Weil, et al.
The Annals of Thoracic Surgery|November 25, 2010
Surgical treatment of atrial fibrillation: the time is nowJeffrey A Poynter, Daniel J Beckman, Aaron M Abarbanell, et al.
Pageof 10